Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With PD or AD and in Healthy Subjects

Clinical trial NCT00612872 · TERMINATED

Trial details

NCT number: NCT00612872
Sponsor: Institute for Neurodegenerative Disorders
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Parkinson Disease Alzheimer Disease Healthy Controls Multiple Sclerosis

Start date: 2008-01-01
Primary completion: 2009-11-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.